Regulation of Body Weight by Proopiomelanocortin Peptides in Humans: Lessons from the Nelson Syndrome

  1. Rajagopal V. Sekhar, MD;
  2. J. Clay Goodman, MD;
  3. Ashok Balasubramanyam, MD;
  4. Jeffrey B. Tatro, PhD; and
  5. Emese Mihaly, PhD
  1. From Baylor College of Medicine, Houston, TX 77030; Tufts University School of Medicine, Boston, MA 02111; and Semmelwies University Medical School, 1088 Budapest, Hungary.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Background: Melanocortins (α-melanocyte-stimulating hormone [MSH] and adrenocorticotropic hormone [ACTH]), in addition to their melanocyte-stimulating actions, may regulate energy balance through hypothalamic melanocortin-4 receptors (MC4Rs). In mice, deletion of the proopiomelanocortin (POMC) or MC4R genes leads to obesity, whereas administration of MC4R agonists (for example, MSH) causes weight loss (1). In humans, inactivating mutations of the POMC (2) or MC4R (3) genes can cause obesity, but there is no evidence that increased melanocortin action can cause weight loss.

    In the Nelson syndrome, rapid growth of an adrenocorticotrophic pituitary adenoma following bilateral adrenalectomy causes extreme elevation of melanocortin levels and hyperpigmentation. The Nelson syndrome is a human model in which temporal associations among body weight, skin pigmentation, and …

    « Previous | Next Article »Table of Contents